PIII Earnings Prediction
The chart below shows how PIII performed 10 days before and after its earnings report, based on data from the past quarters. Typically, PIII sees a -13.65% change in stock price 10 days leading up to the earnings, and a -7.42% change 10 days following the report. On the earnings day itself, the stock moves by -0.66%. This data can give you a slight idea of what to expect for the next quarter's release.
PIII Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
362.12M
25.58%
-4.49%
Gross Margin
-16.97%
288.33%
735.96%
Operating Margin
-31.27%
165.22%
308.22%
Net Margin
-28.40%
119.64%
274.18%
EPS
-0.29
-141.67%
222.22%
No Data Available
PIII Earnings Analysis
P3 Health Partners Inc. Common Stock Corporation (PIII.O) Earnings Conference Call
Positive
Q3 Revenue Growth: P3 Health Partners reported a total revenue of $362.1 million for Q3 2024, representing a 26% year-over-year growth.
Member Base Expansion: The member base expanded significantly, growing by 22% compared to last year, now exceeding 128,900 members.
Funding Increase Impact: Funding rose by approximately 6% year-over-year, contributing positively to financial stability.
Cash Position and Growth Support: The company ended the quarter with approximately $63 million in cash, supporting core operations and strategic growth initiatives.
Contract Enhancement Strategy: P3 Health Partners is actively enhancing payer and provider contracts, which are expected to improve operational efficiency and profitability.
Negative
Quarterly Adjusted EBITDA Loss: Adjusted EBITDA loss for the quarter was $71 million or $184 on a PMPM basis.
Medical Margin Adjusted EBITDA: Our third quarter medical margin adjusted EBITDA results were driven by an incremental $5 million to $10 million in medical claims costs and approximately $35 million of retroactive adjustments.
Cost Management Challenges: During the quarter, we actually saw improvements in Part A costs, but like our peers in the sector, we faced headwinds in Part B expenses and significant retroactive adjustments, which added to the complexity of our quarterly results.
Cost Increase Factors: The increase in costs was related to unexpected prior year and in-year retroactive adjustments; revision of current year run rates; and increased operating expenses associated with higher professional fees supporting our operations as a public company and a non-income-based tax adjustment.
Negative Cash Flow: Our third quarter cash flow from operations for the quarter was approximately negative $20 million.
PIII FAQs
How does PIII typically perform around its earnings report dates?
Is P3 Health Partners Inc. (PIII) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
PIII Earning Call Sentiment
P3 Health Partners Inc. (PIII) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
PIII.O
2.53%Positive
The earnings call reveals several concerns: negative cash flow, high-cost claims, and increased expenses. The Q&A highlights unclear management responses, particularly regarding revenue expectations and benefit design changes. Despite revenue growth, the negative cash flow and lack of shareholder return plan contribute to a negative sentiment. Additionally, the company's exit from the Florida market and competitive pressures further weigh on the outlook. These factors suggest a negative stock price reaction over the next two weeks.
